SINGLE DOSE KINETICS OF DEUTERIUM LABELED DELTA-1-TETRAHYDROCANNABINOL IN HEAVY AND LIGHT CANNABIS USERS

被引:81
作者
OHLSSON, A
LINDGREN, JE
WAHLEN, A
AGURELL, S
HOLLISTER, LE
GILLESPIE, HK
机构
[1] KAROLINSKA INST,DEPT PHARMACOL,S-10401 STOCKHOLM 60,SWEDEN
[2] VET ADM HOSP,PALO ALTO,CA 94304
[3] ASTRA LAKEMEDEL AB,S-15185 SODERTALJE,SWEDEN
来源
BIOMEDICAL MASS SPECTROMETRY | 1982年 / 9卷 / 01期
关键词
D O I
10.1002/bms.1200090103
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
引用
收藏
页码:6 / 10
页数:5
相关论文
共 16 条
[1]  
AGURELL S, 1971, ACTA PHARM SUEC, V8, P391
[2]   STUDIES WITH DEUTERATED DRUGS [J].
BLAKE, MI ;
CRESPI, HL ;
KATZ, JJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (03) :367-391
[3]   PHARMACOKINETICS OF DELTA-9-TETRAHYDROCANNABINOL IN DOGS [J].
GARRETT, ER ;
HUNT, CA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (03) :395-407
[4]  
HOLLISTER LE, 1979, MARIHUANA BIOL EFFEC, P585
[5]  
JONES RT, 1978, DRUGS ABUSE, V12, P373
[6]  
KANTER SL, 1977, RES COMMUN CHEM PATH, V17, P421
[7]  
KNAPP DR, 1972, CLIN PHARMACOL THER, V13, P307
[8]   DELTA-9-TETRAHYDROCANNABINOL - METABOLISM AND DISPOSITION IN LONG-TERM MARIHUANA SMOKERS [J].
LEMBERGER, L ;
TAMARKIN, NR ;
AXELROD, J ;
KOPIN, IJ .
SCIENCE, 1971, 173 (3991) :72-+
[9]   PLASMA DELTA-9-TETRAHYDROCANNABINOL CONCENTRATIONS AND CLINICAL EFFECTS AFTER ORAL AND INTRAVENOUS ADMINISTRATION AND SMOKING [J].
OHLSSON, A ;
LINDGREN, JE ;
WAHLEN, A ;
AGURELL, S ;
HOLLISTER, LE ;
GILLESPIE, HK .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (03) :409-416
[10]  
OHLSSON A, 1976, National Institute on Drug Abuse Research Monograph, V7, P48